Avita Medical | 1811094D - Gross Profit On Sales



Avita Medical reported AUD16.13M in Gross Profit on Sales for its fiscal semester ending in December of 2024.


Gross Profit On Sales Change Date
Adcock Ingram Holdings ZAR 1.54B 73.26M Dec/2024
Celltrion KRW 442.87B 100.93B Mar/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Cochlear AUD 881.7M 14.5M Dec/2024
CSL USD 4.28B 939M Dec/2024
Cspc Pharmaceutical CNY 4.71B 391.66M Mar/2025
Dianthus Therapeutics 193K 970K Jun/2025
Divis Laboratories Ltd 14.54B 1.5B Jun/2025
Kangmei Pharma CNY 223.73M 38.54M Mar/2025
Knight Therapeutics CAD 45.02M 2.32M Sep/2024
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Malin Corporation EUR 3.8M 2.6M Dec/2020
Mayne Pharma AUD 115.99M 63.1M Jun/2024
Medical Developments International AUD 14.72M 1.36M Dec/2024
Nanosonics AUD 73.44M 38.94M Dec/2024
Organigram Holdings CAD 26.15M 25.1M Jun/2025
Pacific Edge 283K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 414.94K 4.82M Dec/2024
Pharma Mar EUR 53.61M 18.15M Jun/2025
Polynovo AUD 23.26M 22.74M Jun/2024
PYC Therapeutics AUD 6.58M 2.13M Jun/2024
Qiagen NV USD 334.29M 25.6M Jun/2025
Ramsay Health Care AUD 6.32B 20.5M Dec/2024
ResMed USD 829.44M 78.16M Jun/2025
Sartorius EUR 416.2M 14.8M Jun/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024
Tilray USD 61.22M 1.51M Nov/2024
Zz Pientze Pharmaceu 296.13M 1.1B Jun/2025